Follow
Wan Wang
Wan Wang
Formulation Scientist, Pfizer
Verified email at pfizer.com
Title
Cited by
Cited by
Year
A hybrid protein–polymer nanoworm potentiates apoptosis better than a monoclonal antibody
SR Aluri, P Shi, JA Gustafson, W Wang, YA Lin, H Cui, S Liu, PS Conti, ...
ACS nano 8 (3), 2064-2076, 2014
712014
A thermo-responsive protein treatment for dry eyes
W Wang, A Jashnani, SR Aluri, JA Gustafson, PY Hsueh, F Yarber, ...
Journal of controlled release 199, 156-167, 2015
642015
Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticles
W Wang, J Despanie, P Shi, MC Edman, YA Lin, H Cui, M Heur, ME Fini, ...
Journal of Materials Chemistry B 2 (46), 8131-8141, 2014
632014
Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells
W Wang, PG Sreekumar, V Valluripalli, P Shi, J Wang, YA Lin, H Cui, ...
Journal of Controlled Release 191, 4-14, 2014
572014
Intra-vitreal αB crystallin fused to elastin-like polypeptide provides neuroprotection in a mouse model of age-related macular degeneration
PG Sreekumar, Z Li, W Wang, C Spee, DR Hinton, R Kannan, JA MacKay
Journal of controlled release 283, 94-104, 2018
442018
Switchable elastin-like polypeptides that respond to chemical inducers of dimerization
J Dhandhukia, I Weitzhandler, W Wang, JA MacKay
Biomacromolecules 14 (4), 976-985, 2013
352013
Bifunctional elastin-like polypeptide nanoparticles bind rapamycin and integrins and suppress tumor growth in vivo
JP Dhandhukia, P Shi, S Peddi, Z Li, S Aluri, Y Ju, D Brill, W Wang, ...
Bioconjugate chemistry 28 (11), 2715-2728, 2017
342017
Thermally-responsive loading and release of elastin-like polypeptides from contact lenses
W Wang, C Lee, M Pastuszka, GW Laurie, JA MacKay
Pharmaceutics 11 (5), 221, 2019
162019
Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers
JA MacKay, W Wang
US Patent 9,102,763, 2015
52015
Elastin-like polypeptide (ELP) fused to an αB crystallin mini-chaperone protects RPE cells from oxidant injury
P Sreekumar, W Wang, J MacKay, C Spee, S Ryan, R Kannan, D Hinton
Investigative Ophthalmology & Visual Science 54 (15), 6075-6075, 2013
12013
αB crystallin peptide fused to elastin-like polypeptide provides long-term neuroprotection in a mouse model of AMD
PG Sreekumar, Z Li, W Wang, C Spee, JA MacKay, DR Hinton, R Kannan
Investigative Ophthalmology & Visual Science 59 (9), 2457-2457, 2018
2018
Compositions and methods for the delivery of drugs to the ocular surface by contact lenses
JA MacKay, W Wang, GW Laurie
US Patent App. 14/781,226, 2018
2018
αB crystallin peptide recombinantly fused with elastin-like polypeptides protects retina from NaIO3-induced RPE atrophy
PG Sreekumar, Z Li, W Wang, C Spee, JA MacKay, DR Hinton, R Kannan
Investigative Ophthalmology & Visual Science 58 (8), 1923-1923, 2017
2017
Treatment of the Cornea Using Transcytotic Delivery into the Tear Film
JA MacKay, W Wang, MC Edman, PY Hseuh, S Hamm-Alvarez, ...
2015
Development of protein polymer therapeutics for the eye
W Wang
University of Southern California, 2014
2014
Bridging ocular therapeutics and contact lenses via thermo-responsive protein polymers
W Wang, P Shi, S Aluri, PY Hsueh, M Edman, D Ryan, R McKown, ...
Investigative Ophthalmology & Visual Science 54 (15), 2668-2668, 2013
2013
Ocular Drug Delivery Using A Thermo-responsive Lacritin Fusion Protein
JA MacKay, W Wang, B Droese, M Shah, PY Hsueh, G Sun, ...
Investigative Ophthalmology & Visual Science 53 (14), 492-492, 2012
2012
Ocular delivery of a model biopharmaceutical, lacritin, using protein polymers
JA MacKay, W Wang, P Hsueh, M Edman-Woolcott, SF Hamm-Alvarez
The system can't perform the operation now. Try again later.
Articles 1–18